Ultragenyx Pharmaceutical Inc. — Form D
Ultragenyx Pharmaceutical Inc. of Novato, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-12-31. The offering totals $75.0M, of which $75.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-12-31
- Form: D
- Accession: 0001565063-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $75.0M
- Amount sold: $75.0M
- Investors: 34
- Date of first sale: 2012-12-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-189181
Issuer
- Name: Ultragenyx Pharmaceutical Inc.
- CIK: 0001515673
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 60 Leveroni Court, Novato, CA, 94949
- Phone: 415.483.8800
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| WILLIAM D ALISKI | Director | NOVATO, CA |
| BEN D AUSPITZ | Director | NOVATO, CA |
| EMIL D KAKKIS | Director | NOVATO, CA |
| ERAN D NADAV | Director | NOVATO, CA |
| MARTEN D STEEN | Director | NOVATO, CA |
| JOHN D DITTON | Executive Officer | NOVATO, CA |
| STEVEN D JUNGLES | Executive Officer | NOVATO, CA |
| EMIL D KAKKIS | Executive Officer | NOVATO, CA |
| THOMAS D KASSBERG | Executive Officer | NOVATO, CA |
| CORDELIA D LEONARD | Executive Officer | NOVATO, CA |
| SHALINI D SHARP | Executive Officer | NOVATO, CA |
| VIMAL D SRIVASTAVA | Executive Officer | NOVATO, CA |
| Ben Auspitz | Director | Cambridge, MA |
| EMIL KAKKIS | Director | NOVATO, CA |
| EMIL KAKKIS | Executive Officer | NOVATO, CA |
| Marten Steen | Director | Lausanne, V8 |
| William Aliski | Director | Novato, CA |
| Eran Nadav | Director | San Francisco, CA |
| Bill Aliski | Director | Novato, CA |
| Jenny Soriano | Director | Novato, CA |
| John Ditton | Executive Officer | Novato, CA |
| John Klock | Director | Novato, CA |
Other filings by this issuer (3)
More